Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Mullen, Jaren
7  Ergebnisse:
Personensuche X
?
1

A comprehensive and healthcare equity promoting response by..:

Rodríguez, Ana Laura ; Aranda, Zeus ; Brun, Elvire...
BMJ Global Health.  8 (2023)  3 - p. e011244 , 2023
Link: https://doi.org/10.1136/..
 
?
2

Combination high-dose interleukin-2 and nivolumab for progr..:

Nikanjam, Mina ; Mullen, Jaren ; Yacoub, Carol.
Journal of Medical Case Reports.  16 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
3

Targeting ARID1A mutations in cancer:

Mullen, Jaren ; Kato, Shumei ; Sicklick, Jason K..
Cancer Treatment Reviews.  100 (2021)  - p. 102287 , 2021
Link: https://doi.org/10.1016/..
 
?
4

A comprehensive and healthcare equity promoting response by..:

Rodríguez, Ana Laura ; Aranda, Zeus ; Brun, Elvire...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030274/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Combination high-dose interleukin-2 and nivolumab for progr..:

Nikanjam, Mina ; Mullen, Jaren ; Yacoub, Carol.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429475/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Combination high-dose interleukin-2 and nivolumab for progr..:

Nikanjam, Mina ; Mullen, Jaren ; Yacoub, Carol.
qt5qq0v8qd.  , 2022
Link: https://escholarship.org..
 
?
7

Combination high-dose interleukin-2 and nivolumab for progr..:

Mina Nikanjam ; Jaren Mullen ; Carol Yacoub.
https://doi.org/10.1186/s13256-022-03536-y.  , 2022
Link: https://doi.org/10.1186/..
 
1-7